Table 1.
Patient characteristics in Protein array group and validation group.
| Protein array group
|
Validation group
|
|||||||
|---|---|---|---|---|---|---|---|---|
| HCC | HBV and/or HCV carrier | HCC | HBV and/or HCV carrier | |||||
| N | (%) | N | (%) | N | (%) | N | (%) | |
| Age group (years) | ||||||||
| <50 | 9 | (18.8) | 5 | (26.3) | 3 | (13.0) | 11 | (50.0) |
| ≥50 | 39 | (81.2) | 14 | (73.7) | 20 | (87.0) | 11 | (50.0) |
| Gender | ||||||||
| Male | 39 | (81.3) | 14 | (73.7) | 19 | (82.6) | 13 | (59.1) |
| Female | 9 | (18.8) | 5 | (26.3) | 4 | (17.4) | 9 | (40.9) |
| Race | ||||||||
| Asian/Pacific Islander | 34 | (70.8) | 11 | (57.9) | 20 | (87.0) | 16 | (72.7) |
| White, non-Hispanic | 11 | (22.9) | 8 | (42.1) | 3 | (13.0) | 6 | (27.3) |
| Other/unknown | 3 | (6.3) | 0 | (0.0) | 0 | 0 | ||
| Hepatitis virus seropositivity (HCC cases only) | ||||||||
| HBV-positive | 26 | (54.2) | 17 | (73.9) | ||||
| HCV-positive | 10 | (20.8) | 4 | (17.4) | ||||
| HBV- and HCV-positive | 1 | (2.1) | 1 | (4.3) | ||||
| None/unknown | 11 | (22.9) | 1 | (4.3) | ||||
| Peak alpha-fetoprotein (ng/ml) | ||||||||
| <20 | 18 | (37.5) | 17 | (89.5) | 5 | (21.7) | 8 | (36.4) |
| 20–199 | 16 | (33.3) | 2 | (10.5) | 8 | (34.8) | 0 | (0.0) |
| ≥200 | 13 | (27.1) | 0 | (0.0) | 10 | (43.5) | 0 | (0.0) |
| Unknown | 1 | (2.1) | 0 | (0.0) | 0 | (0.0) | 14 | (63.6) |
| Median | 39.7 | 4.9 | 69.4 | 5.27 | ||||